Nebido® product information
Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests. Long-term therapy with Nebido® may increase the improvement of erectile dysfunction and sexual mood, metabolic syndrome, and may restore muscle mass and strength through treatment of hypogonadism.
Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk.
Adverse events should also be reported to Bayer plc, Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.
If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc, Email: qualitycomplaints@bayer.com
For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.
Restore the man is organised and funded by Bayer and may contain some promotional content.
Licensed for: In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
Nebido® (testosterone undecanoate) Prescribing Information
This website is intended for Healthcare Professionals resident in the UK.
Page last modified 29 Sep 2020
- PP-NEB-GB-0328 November 2020
